Institute for Clinical and Economic Review
The Institute for Clinical and Economic Review (ICER) is an independent, non-profit research institute that conducts evidence-based reviews of health care interventions, including prescription drugs, other treatments, and diagnostic tests. In collaboration with patients, clinical experts, and other key stakeholders, ICER analyzes the available evidence on the benefits and risks of these interventions to measure their value and suggest fair prices. ICER also regularly reports on the barriers to care for patients and recommends solutions to ensure fair access to prescription drugs. For more information about ICER, please visit www.icer.org.www.icer.org
2
MENTIONS
2
EPISODES
2
PODCASTS
Search complete. 2 mentions across 2 episodes found for "Institute for Clinical and Economic Review".
Oct 12, 2026
Jason CrowellHOST
We have talked about drug costs on this podcast for several years.
Jason CrowellHOST
We have closely followed the work of ICER, the Institute for Clinical and Economic Review, and the work that they've done in helping us understand the value of drugs.
Jason CrowellHOST
Our multiple sclerosis colleagues are very familiar with the high cost of drugs.
Jason CrowellHOST
We now have these anti-amyloid therapies available for patients with certain neurodegenerative disorders that our cognitive neurologists are using.
Sarah EmondGUEST
It can't be that we continue to just be price takers from the ecosystem without any conversation about whether or not the price is fair or we won't have money to pay for these innovations in the future.
Ellen KelsayHOST
That's Sarah Emond, President and CEO of ICER, the Institute for Clinical and Economic Review.
Ellen KelsayHOST
joining us to provide an update on the market for cell and gene therapies, some of healthcare's most innovative and costly treatments.
Ellen KelsayHOST
I'm Ellen Kelsey, and this is the Business Group on Health podcast, conversations with experts on the most relevant health and well-being issues facing employers.